Literature DB >> 8681613

Contribution of lung and chest wall mechanics following emphysema resection.

A F Gelb1, R J McKenna, M Brenner, R Fischel, A Baydur, N Zamel.   

Abstract

OBJECTIVE: To determine the contributions of (1) chest wall (Pcw) and (2) lung elastic recoil pressure (PL) to (3) total elastic recoil pressure exerted by the respiratory system (Prs) in 18 patients (12 men) aged 66 +/- 6 years (mean +/- 1 SD) with severe emphysema who underwent video-assisted thoracoscopic bilateral lung volume reduction surgery under paralyzed (vecuronium) general anesthesia (isoflurane).
DESIGN: We measured preoperative and 6-week postoperative lung function studies, and intraoperative inspiratory lung conductance (GL), PL, Pcw, and Prs (cm H2O) at end-expiratory lung volume (EELV), EELV plus 0.60 +/- 0.0 L, and EELV plus 1.15 +/- 0.0 L. All values are mean +/- SEM.
RESULTS: Preoperative vs postoperative FVC was 1.9 +/- 0.1 L vs 2.3 +/- 0.1 L (p = 0.03); FEV1 was 0.6 +/- 0.1 L vs 0.9 +/- 0.1 L (p < 0.02); total lung capacity was 7.4 +/- 0.4 L vs 5.9 +/- 0.3 L (p < 0.001); functional residual capacity was 5.7 +/- 0.4 L vs 4.4 +/- 0.2 L (p = 0.001). At EELV preoperative vs postoperative, PL was 0.0 +/- 0.3 vs 1.1 +/- 0.05 (p = 0.04), Pcw was 5.0 +/- 0.7 vs 2.4 +/- 0.9 (p = 0.02), and Prs was 5.0 +/- 0.8 vs 3.5 +/- 0.7 (p = 0.08). AT EELV plus 0.60 L, PL was 3.2 +/- 0.6 vs 6.1 +/- 0.9 (p < 0.001), Pcw was 8.8 +/- 0.8 vs 7.0 +/- 0.9 (p = 0.12), and Prs was 12.0 +/- 0.8 vs 13.1 +/- 0.7 (p = 0.80). At EELV plus 1.15 L, PL was 6.8 +/- 0.9 vs 10.3 +/- 1.1 (p < 0.001), Pcw was 13.5 +/- 1.0 vs 11.2 +/- 1.2 (p = 0.12), and Prs was 20 +/- 1.2 vs 21.5 +/- 1.0 p = 0.93). AT EELV plus 0.06 L, GL was 0.09 +/- 0.00 L/S/cm H2O vs 0.16 +/- 0.01 (p < 0.01). At EELV plus 1.15 L, GL was 0.12 +/- 0.01 vs 0.21 +/- 0.03 (p < 0.05) with similar preoperative vs postoperative GL/PL slopes.
CONCLUSION: The increase in PL and decrease in Pcw following LVRS for emphysema may be responsible for the increase in spirometry and airway conductance.

Entities:  

Mesh:

Year:  1996        PMID: 8681613     DOI: 10.1378/chest.110.1.11

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Physiologic basis for improved pulmonary function after lung volume reduction.

Authors:  Henry E Fessler; Steven M Scharf; Edward P Ingenito; Robert J McKenna; Amir Sharafkhaneh
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

2.  Insight on emphysema--the first 300 cases of surgical treatment.

Authors:  R J Fischel; R J McKenna; A Gelb; N Singh; M Brenner
Journal:  West J Med       Date:  1998-08

Review 3.  Assessment and monitoring of flow limitation and other parameters from flow/volume loops.

Authors:  R Dueck
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

Review 4.  Airway-parenchymal interdependence.

Authors:  Peter D Paré; Wayne Mitzner
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

5.  Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysema in ever-smokers.

Authors:  Sean E Hesselbacher; Robert Ross; Matthew B Schabath; E O'Brian Smith; Sarah Perusich; Nadia Barrow; Pamela Smithwick; Manoj J Mammen; Harvey Coxson; Natasha Krowchuk; David B Corry; Farrah Kheradmand
Journal:  Int J Environ Res Public Health       Date:  2011-04-29       Impact factor: 3.390

6.  Radiofrequency therapy improves exercise capacity of mice with emphysema.

Authors:  Mai Tsutsui; Chung Yan Cheung; Takeyuki Wada; Jen-Erh Jaw; Cheng Wei Tony Yang; Pascal Bernatchez; Zoe White; Chen Xi Yang; Eun Jeong Annie Bae; Lauren H Choi; Dan Gelbart; Samuel Lichtenstein; Lindsay Machan; Eran Elizur; Kim Wolff; Evan Goodacre; Marek Lipnicki; Denny Wong; Don D Sin
Journal:  Sci Rep       Date:  2021-10-08       Impact factor: 4.379

Review 7.  Endoscopic bronchial valve treatment: patient selection and special considerations.

Authors:  Ralf Eberhardt; Daniela Gompelmann; Felix J F Herth; Maren Schuhmann
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.